Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
TLX Announcements
FDA Alignment to Advance ProstACT…
TLX
TELIX PHARMACEUTICALS LIMITED
Market sensitive
FDA Alignment to Advance ProstACT Global Phase 3 Trial
Date and time
2 July 2026 at 8:07 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
TLX announcement history
Recent TLX announcements
Telix HY26 Results Presentation
Telix HY26 Results Announcement
Telix HY26 Appendix 4D and Interim Report
Telix H1 2026 Results - Investor Webcast Notification
Change in substantial holding
Q2 2026 Revenue US$247M Strong Momentum Pipeline Progress